Dr. Alma Delia Valencia Camargo

Dr. Alma Delia Valencia Camargo

Staff of Professorship for Pharmaceutical Immunology

ETH Zürich

Pharmaceutical Immunology

HCI G 390

Vladimir-Prelog-Weg 1-5/10

8093 Zürich

Switzerland

Alma

Research interests 

  • Role of microfold cells in lung immunity
  • Tertiary Lymphoid Structures in tumor immunology

Education & positions held

2025 - present
Postdoctoral researcher with Dr. Karina Silina and Prof. Cornelia Halin, Institute of Pharmaceutical Sciences, Pharmaceutical Immunology, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland

2024 - 2025
Postdoctoral researcher with Prof. Dr. Christian Münz, Institute of Experimental Immunology, University of Zürich (UZH), Zurich, Switzerland

2019 - 2024
PhD student with Prof. Dr. Christian Münz, Institute of Experimental Immunology, University of Zürich (UZH), Zurich, Switzerland

2017 - 2018
Research assistant in adjuvants and vaccines at Mexican Social Security Institute (IMSS), Mexico City, Mexico

2016
Research assistant in animal virology and vaccines at University of Guadalajara (UdG), Guadalajara, Mexico

Immunology lecturer at Technology Institute of Western Higher Education (ITESO), Guadalajara, Mexico

2014 - 2016
Master student with Dr. Susana Lopez Charreton at Biotechnology Institute, National Autonomous University of Mexico (UNAM), Morelos, Mexico

2012 - 2013
Bachelor student with Dr. Susana Romero Garcia at National Institute of Respiratory Diseases, Mexico City, Mexico

Publications 

Valencia-Camargo, A.D.; Vanoaica, L.D.; Silva, P.; Gasbarri, M.; Hahn, A.S.; Stellacci, F. and Münz, C. Sulfonated cyclodextrins are virucidal against KSHV and EBV, and attenuate KSHV infection in vivo. Manuscript under peer review at eBioMedicine.

Valencia-Camargo, A.D.; Schuhmachers, P.; Rühl, J.; Boudewijns, R.; Thibaut, H.J.; Dallmeier, K. and Münz, C. A YF17D-vectored EBV vaccine candidate protects against tumor formation in humanized mouse model. Manuscript in preparation.

Kirchmeier, D.; Deng, Y.; Rieble, L.; Böni, M.; Läderach, F.; Schuhmachers, P.; Valencia-Camargo, A.D.; Murer, A.; Caduff, N.; Chatterjee, B.; Chijioke, O.; Zens, K. and Münz, C. (2024). Epstein Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues. JCI insight. doi: 10.1172/jci.insight.173489

Zhu, Y.; Gasbarri, M.; Zebret, S.; Pawar, S.; Mathez, G.; Diderich, J.; Valencia-Camargo, A.D.; Russenberger, D.; Wang, H.; Silva, P.; Dela Cruz, J.; Wei, L.; Cagno, V.; Münz, C.; Speck, R.; Desmech, D. and Stellacci, F. (2024). Benzene with Alkyl Chains is a Universal Scaffold for Multivalent Virucidal Antivirals. ACS Central Science. doi: 10.1021/acscentsci.4c00054

Pena-Francesch, M.; Vanoaica, L.D.; Zhu, G.F.; Stumpe, M.; Sankar, D.S.; Nowag, H.; Valencia-Camargo, A.D.; Hammerschmidt, W.; Dengjel, J.; Ligeon, L-A. and Münz, C. (2023). The autophagy machinery interacts with EBV capsids for secretion of viral envelopes. PNAS. doi: 10.1073/pnas.2211281120

Läderach, F.; Zdimerova, H.; Rieble, L.; Schuhmachers, P.; Engelmann, C.; Valencia-Camargo, A.D.; Kirchmeier, D.; Böni, M. and Münz, C. (2023). MHC class II-deficient mice allow functional human CD4+ T-cell development. Eur J Immunol. doi: 10.1002/eji.202250313